In-Process Controls Explained
In-Process Controls (IPC) are a central mechanism for ensuring that manufacturing processes remain within validated parameters. They support the process capability framework outlined in Pharmaceutical GMP Compliance by helping maintain control during routine manufacturing.
While final product testing confirms whether specifications are met, in-process controls are designed to prevent failures before they occur. They provide real-time oversight of critical process variables and help maintain consistent product quality.
Regulators expect in-process controls to be scientifically justified, risk-based, and aligned with validated process parameters.
What Are In-Process Controls?
In-process controls are checks, tests, or measurements performed during manufacturing to monitor and control process performance.
They may include:
Weight variation checks
Tablet hardness testing
Blend uniformity testing
pH measurements
Temperature and pressure monitoring
Fill volume checks
Moisture content testing
IPCs are not optional quality checks. They are part of the validated manufacturing process.
Why In-Process Controls Matter
IPCs serve several critical functions:
Detect process drift early
Prevent batch failure
Reduce reliance on end-product testing
Maintain validated state
Support real-time quality assurance
IPCs provide evidence that the process remains within established operating ranges.
The broader lifecycle approach to process validation is discussed in Process Validation: Stage 1-3 Explained.
Without effective IPCs, validation assumptions may not hold under routine production conditions.
IPCs vs Final Product Testing
It is important to distinguish between:
In-process controls - monitoring during production
Final product testing - verification after production
Final testing confirms compliance with specifications.
IPCs help ensure the process stays on track.
An overreliance on final testing suggests weak process control.
Modern GMP philosophy emphasizes building quality into the process rather than relying solely on end-product inspection.
Defining IPC Parameters
In-process controls should be based on:
Critical Process Parameters (CPPs)
Critical Quality Attributes (CQAs)
Risk assessments
Process validation data
Parameters selected for monitoring must have a scientific rationale.
For example:
Compression force may affect tablet hardness.
Mixing time may affect blend uniformity.
Drying temperature may influence moisture content.
IPCs should directly monitor variables linked to product quality risk.
Sampling Frequency and Strategy
IPCs must define:
Sampling frequency
Sampling size
Acceptable criteria
Escalation triggers
Sampling should be risk-based.
For example:
Higher-risk processes may require more frequent checks.
Automated continuous monitoring may replace manual sampling in certain systems.
Inadequate sampling frequency is a common inspection concern.
Sampling plans must reflect process understanding, not convenience.
Documentation and Traceability
IPCs must be:
Clearly defined in batch records
Executed as written
Documented contemporaneously
Reviewed appropriately
Batch record design and execution are discussed in Master vs Executed Batch Records.
Failure to document IPC results accurately may compromise batch disposition decisions.
Regulators often evaluate IPC documentation closely during batch record review.
Out-of-Trend vs Out-of-Specification IPC Results
Not all IPC deviations are equal.
Organizations should distinguish between:
Out-of-specification (OOS) results - exceeding defined limits
Out-of-trend (OOT) results - showing drift within limits
OOT signals may indicate emerging process instability.
Failure to investigate recurring OOT trends can result in later batch failures.
Formal investigation requirements for OOS events are discussed in Out-of-Specification (OOS) Investigations.
IPCs must feed into deviation management systems when appropriate.
When in-process controls indicate that parameters are outside acceptable limits, product may need to be managed as non-conforming, as addressed in Control of Non-Conforming Product.
Operator Role in IPC Execution
Operators play a critical role in:
Performing measurements
Interpreting results
Escalating concerns
Recording data accurately
Training effectiveness directly affects IPC reliability.
If operators cannot recognize abnormal results or fail to escalate concerns, IPCs lose preventive value.
Automation and Digital IPC Monitoring
Modern manufacturing environments may use:
Real-time sensors
Automated weight control systems
Statistical process control software
Manufacturing Execution Systems (MES)
Automation can enhance detection sensitivity but requires:
Defined alarm limits
Clear response procedures
Audit trail review
Controlled data integrity practices
Digital IPC systems must remain aligned with validated process parameters.
Common Inspection Findings Related to IPCs
Regulators frequently observe:
IPC parameters not aligned with validated ranges
Inconsistent sampling frequency
Missing documentation
Failure to investigate recurring trends
Poor linkage between IPC deviations and root cause analysis
Weak IPC programs often indicate superficial process understanding.
Inspectors assess whether IPCs are meaningful controls - not just procedural steps.
Operational Perspective
In-process controls are preventive safeguards embedded within the manufacturing process.
They demonstrate that the process remains under control between validation and final testing.
A mature IPC program:
Links parameters to risk
Defines justified sampling strategies
Escalates abnormal trends
Documents execution accurately
Integrates with deviation management
When IPCs are scientifically justified and consistently executed, they provide regulators confidence that the product quality is controlled in real time - not verified after the fact.
